Dynavax to Present at the Cowen 40th Annual Health Care Conference
February 18 2020 - 4:05PM
Dynavax Technologies Corporation (NASDAQ: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, today announced that Ryan Spencer, Chief Executive
Officer, will present at the Cowen 40th Annual Health Care
Conference on Monday, March 2, at 1:30 p.m. E.T.
The presentation will be webcast and may be
accessed through the “Events & Presentations” page on the
“investors” section of the Company’s website at
http://investors.dynavax.com/events-presentations.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. For more information,
visit www.dynavax.com and follow the company on LinkedIn.
Contacts:
Nicole Arndtnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations Advisory
Solutionsderek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024